These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12121069)

  • 1. Blood program in Japan: current status.
    Ikeda H
    Transfus Apher Sci; 2002 Apr; 26(2):129-33. PubMed ID: 12121069
    [No Abstract]   [Full Text] [Related]  

  • 2. Is there a limit to the normality of blood products?
    Degos L
    Hematol J; 2000; 1(5):291. PubMed ID: 11920204
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of the leuko-reductive efficacy of single-donor erythropheresis procedures].
    Domingo JM; Rabasa P; Chueca P; Medarde A
    Sangre (Barc); 1999 Jun; 44(3):238-40. PubMed ID: 10481589
    [No Abstract]   [Full Text] [Related]  

  • 4. Blood supply safety: an NHLBI perspective.
    Glynn SA
    Transfusion; 2008 Aug; 48(8):1541-4. PubMed ID: 18713102
    [No Abstract]   [Full Text] [Related]  

  • 5. Safe blood transfusion practices in blood banks of Karachi, Pakistan.
    Kassi M; Afghan AK; Khanani MR; Khan IA; Ali SH
    Transfus Med; 2011 Feb; 21(1):57-62. PubMed ID: 21029219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of the blood supply.
    Sloand EM; Pitt E; Klein HG
    JAMA; 1995 Nov; 274(17):1368-73. PubMed ID: 7563562
    [No Abstract]   [Full Text] [Related]  

  • 7. How we provide blood transfusion support in two large US liver transplant programs.
    Zubair AC; Torp K; Eichbaum Q
    Transfusion; 2016 Aug; 56(8):1938-43. PubMed ID: 27338113
    [No Abstract]   [Full Text] [Related]  

  • 8. [Leukocyte depletion of blood products: a requirement for improvement of quality and safety].
    De Pauw BE; Van den Bos A
    Ned Tijdschr Geneeskd; 2000 Sep; 144(36):1754-6. PubMed ID: 10992905
    [No Abstract]   [Full Text] [Related]  

  • 9. Will blood transfusion ever be safe enough?
    Klein HG
    JAMA; 2000 Jul; 284(2):238-40. PubMed ID: 10889600
    [No Abstract]   [Full Text] [Related]  

  • 10. Biotechnology, economics, and the business of blood.
    Carter TH
    Biotechnology; 1991; 19():3-30. PubMed ID: 1786473
    [No Abstract]   [Full Text] [Related]  

  • 11. Universal donor education and consent: what we know and where we should go.
    Wehrli G; Sazama K
    Transfusion; 2010 Nov; 50(11):2499-502. PubMed ID: 20529003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion services operations during the COVID-19 pandemic: Results from AABB survey.
    Pagano MB; Rajbhandary S; Nunes E; Cohn CS
    Transfusion; 2020 Nov; 60(11):2760-2762. PubMed ID: 33217023
    [No Abstract]   [Full Text] [Related]  

  • 13. French evaluation of conditions for the systematic implementation of leucocyte removal in labile blood products (LBP).
    Chamfly V
    Transfus Sci; 1998 Dec; 19(4):333-42. PubMed ID: 10351148
    [No Abstract]   [Full Text] [Related]  

  • 14. Maximizing blood component donations.
    Fuller MJ
    Vox Sang; 2000; 78 Suppl 2():47-9. PubMed ID: 10938926
    [No Abstract]   [Full Text] [Related]  

  • 15. Current blood transfusion practices in India.
    Arankalle VA
    Indian J Gastroenterol; 2000; 19(2):51-2. PubMed ID: 10812813
    [No Abstract]   [Full Text] [Related]  

  • 16. Transfusion safety: Where are we today?
    Luban NL
    Ann N Y Acad Sci; 2005; 1054():325-41. PubMed ID: 16339681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfusion reactions: a comparative observational study of blood components produced before and after implementation of semiautomated production from whole blood.
    Semple E; Bowes-Schmidt A; Yi QL; Shimla S; Devine DV
    Transfusion; 2012 Dec; 52(12):2683-91. PubMed ID: 22738255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leucocyte fragments in 'prestorage-leucodepleted' blood products: a qualitative analysis.
    Sivakumaran M; Saunders P; Hanmer D; Drury M; Seghatchian J
    Transfus Sci; 2000; 22(1-2):81-2. PubMed ID: 10771391
    [No Abstract]   [Full Text] [Related]  

  • 19. Reducing the residual risk of transfusion-transmitted viruses: mini-pool or single-donation NAT?
    Roth WK; Seifried E
    Transfusion; 2001 Jun; 41(6):845-7. PubMed ID: 11399831
    [No Abstract]   [Full Text] [Related]  

  • 20. The quality of blood starts with its collection.
    Loos JA
    Vox Sang; 1994; 67 Suppl 3():77-9. PubMed ID: 7975516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.